Complete remission of rare adenocarcinoma of the oropharynx with APCEDEN (®) (dendritic cell‐based vaccine): a case report

APCEDEN (®) is an autologous monocyte‐derived dendritic cell‐based immunotherapy. A 58‐year‐old man with adenocarcinoma of oropharynx shows complete remission after receiving APCEDEN (®) in conjunction with Geftinib validated by reduction in size, whereas Gefitinib alone lead to disease progression....

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Chaitanya, Kohli, Sakshi, Chiliveru, Srikanth, Jain, Minish, Sharan, Bandana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628247/
https://www.ncbi.nlm.nih.gov/pubmed/29026574
http://dx.doi.org/10.1002/ccr3.1169
_version_ 1783268844462145536
author Kumar, Chaitanya
Kohli, Sakshi
Chiliveru, Srikanth
Jain, Minish
Sharan, Bandana
author_facet Kumar, Chaitanya
Kohli, Sakshi
Chiliveru, Srikanth
Jain, Minish
Sharan, Bandana
author_sort Kumar, Chaitanya
collection PubMed
description APCEDEN (®) is an autologous monocyte‐derived dendritic cell‐based immunotherapy. A 58‐year‐old man with adenocarcinoma of oropharynx shows complete remission after receiving APCEDEN (®) in conjunction with Geftinib validated by reduction in size, whereas Gefitinib alone lead to disease progression.
format Online
Article
Text
id pubmed-5628247
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56282472017-10-12 Complete remission of rare adenocarcinoma of the oropharynx with APCEDEN (®) (dendritic cell‐based vaccine): a case report Kumar, Chaitanya Kohli, Sakshi Chiliveru, Srikanth Jain, Minish Sharan, Bandana Clin Case Rep Case Reports APCEDEN (®) is an autologous monocyte‐derived dendritic cell‐based immunotherapy. A 58‐year‐old man with adenocarcinoma of oropharynx shows complete remission after receiving APCEDEN (®) in conjunction with Geftinib validated by reduction in size, whereas Gefitinib alone lead to disease progression. John Wiley and Sons Inc. 2017-09-07 /pmc/articles/PMC5628247/ /pubmed/29026574 http://dx.doi.org/10.1002/ccr3.1169 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Kumar, Chaitanya
Kohli, Sakshi
Chiliveru, Srikanth
Jain, Minish
Sharan, Bandana
Complete remission of rare adenocarcinoma of the oropharynx with APCEDEN (®) (dendritic cell‐based vaccine): a case report
title Complete remission of rare adenocarcinoma of the oropharynx with APCEDEN (®) (dendritic cell‐based vaccine): a case report
title_full Complete remission of rare adenocarcinoma of the oropharynx with APCEDEN (®) (dendritic cell‐based vaccine): a case report
title_fullStr Complete remission of rare adenocarcinoma of the oropharynx with APCEDEN (®) (dendritic cell‐based vaccine): a case report
title_full_unstemmed Complete remission of rare adenocarcinoma of the oropharynx with APCEDEN (®) (dendritic cell‐based vaccine): a case report
title_short Complete remission of rare adenocarcinoma of the oropharynx with APCEDEN (®) (dendritic cell‐based vaccine): a case report
title_sort complete remission of rare adenocarcinoma of the oropharynx with apceden (®) (dendritic cell‐based vaccine): a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628247/
https://www.ncbi.nlm.nih.gov/pubmed/29026574
http://dx.doi.org/10.1002/ccr3.1169
work_keys_str_mv AT kumarchaitanya completeremissionofrareadenocarcinomaoftheoropharynxwithapcedendendriticcellbasedvaccineacasereport
AT kohlisakshi completeremissionofrareadenocarcinomaoftheoropharynxwithapcedendendriticcellbasedvaccineacasereport
AT chiliverusrikanth completeremissionofrareadenocarcinomaoftheoropharynxwithapcedendendriticcellbasedvaccineacasereport
AT jainminish completeremissionofrareadenocarcinomaoftheoropharynxwithapcedendendriticcellbasedvaccineacasereport
AT sharanbandana completeremissionofrareadenocarcinomaoftheoropharynxwithapcedendendriticcellbasedvaccineacasereport

Ejemplares similares